Genentech, Inc. News on Daylife

East Coast VCs, innovators attract California biotech execs

Fri, 04 Dec 2009 05:39:07 GMT

In the bicoastal battle for biotechnology executive talent, score three for the Bay State. The region has picked up at least three new biotech CEOs from the San Francisco Bay Area in the past few months.
Source: Mass High Tech Business News

Roche licenses Aegis’ Protek to stop peptide aggregation

Thu, 03 Dec 2009 11:39:49 GMT

The pharma industry is increasingly focused on peptide and protein therapeutics, particularly true of Roche following its acquisition of Genentech, and consequently technologies that improve their production are in demand.
Source: InPharmaTechnologist

Seattle Genetics to Present Brentuximab Vedotin and Dacetuzumab Data at the 51st American Society of Hematology Annual Meeting and Exposition

Wed, 02 Dec 2009 21:21:16 GMT

BOTHELL, Wash.--(BUSINESS WIRE)--Dec 1, 2009 - Seattle Genetics, Inc.
Source: Drugs.com

Beating diabetes with B-cell-targeting drugs

Wed, 02 Dec 2009 16:05:01 GMT

Today Asher Mullard Please Login to read the full article.
Source: Scrip News

McDermott Will & Emery Welcomes Biotech Veteran Paul De Stefano

Wed, 02 Dec 2009 15:25:53 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)-- McDermott Will & Emery LLP is pleased to welcome Paul De Stefano, one of the nation's elite attorneys in the biotech industry, to its Silicon Valley office.
Source: Street Insider

A Busy Month For Immunogen (Part I)

Wed, 02 Dec 2009 11:06:09 GMT

The month of December has always been a busy period for biotech investors, due to two important events: The annual meeting of American Society of Hematology (ASH) and the San Antonio Breast Cancer Symposium (SABCS).
Source: iStockAnalyst

Allocate Time for Innovation

Wed, 02 Dec 2009 10:43:38 GMT

One of the commonest barriers to innovation is lack of time. People are just too busy doing their day job to spend time trying new things. The common assumption is that working hard and working long hours are good things and sufficient for success.
Source: BQF Innovation

Genentech Inc.-Deals & Alliances Report - research report released

Wed, 02 Dec 2009 10:16:53 GMT

2009-12-02 11:16:53 - Genentech Inc.-Deals & Alliances Report - a new market research report on companiesandmarkets.com product with detailed descriptions of the partner firm where disclosed, partners in other non-product, non-technology...
Source: PR-Inside.com

Quoted in 'Commentary: Don't let others put words in your mouth'

Wed, 25 Nov 2009 15:44:08 GMT

said in McClatchy:

Genentech, a subsidiary of the Swiss drug giant Roche, estimates that 42 House members picked up some of its talking points - 22 Republicans and 20 Democrats ... Rep. Bill Pascrell Jr., a New Jersey Democrat, said: 'I regret that the language was the same. I did not know it was.'

Quoted in 'Lobbyists Put On Ventriloquist Act'

Mon, 16 Nov 2009 19:54:29 GMT

said in Sunlight Foundation:

lobbyists, employed by Genentech and by two Washington law firms, were remarkably successful in getting the statements printed in the Congressional Record under the names of different members of Congress.

Photo from AP Photo

Thu, 12 Mar 2009 16:06:23 GMT

In this July 10, 2006 file photo, Genentech researcher Mark Nagel works on an experiment in a research laboratory at Genentech headquarters in a South San Francisco, Calif.

Photo from AP Photo

Fri, 06 Mar 2009 05:00:00 GMT

Genentech headquarters in South San Francisco, Calif. seen Friday, March 6, 2009.

Heroes of Hope

Mon, 12 Mar 2007 18:08:50 GMT